Hospital use for COPD patients during the last few years of their life

Respiratory Medicine

Volumn 100, Issue 8, 2006, Pages 1436-1441

  Andersson, Fredrik L ^a,b   Svensson, Klas ^a,b   Gerhardsson de Verdier, Maria ^a,b  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

COPD; End of life; Hospitalisations; Mortality; Resource use

Indexed keywords

AGED; ARTICLE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL UTILIZATION; HUMAN; LENGTH OF STAY; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTER; SURVIVAL TIME; SWEDEN;

AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; PALLIATIVE CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SWEDEN;

EID: 33745642289     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.11.003     Document Type: Article

References (28)

1. Pauwels R.A., Buist A.S., Calverley P.M., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 163 (2001) 1256-1276
2. Murray C.J., and Lopez A.D. Alternative projection of mortality by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
3. Engström G., Wollmer P., Hedblad B., Wollmer P., Stavenow L., Janzon L., et al. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from "men born in 1914," Malmö, Sweden. Circulation 103 (2001) 3086-3091
4. Sin D.D., and Man S.F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107 (2003) 1514-1519
5. Hole D.J., Watt G.C., Davey-Smith G., Hart C.L., Gillis C.R., and Hawthorne V.M. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. Br Med J 313 (1996) 711-715
6. Feenstra T.L., van Genugten M.L.L., Hoogenveen R.T., Wouters E.F., and Rutten-van Mölken M.P.M.H. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 590-596
7. Siafakas N.M., Vermeire P., Pride N.B., Paoletti P., Gibson J., Howard P., et al. ERS consensus statement. Optimal assessment and management of chronic obstructive pulmonary disease. Eur Resp Rev 8 (1995) 1398-1420
8. SBU. Behandling av astma och KOL-en systematisk kunskapssammanställning (Treating asthma and COPD-a systematic review and summary) (2000), The Swedish Council on Technology Assessment in Health Care, Stockholm
9. Rennard S., Decramer M., Calverley P.M.A., Pride N.B., Soriano J.B., Vermeire P.A., et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of confronting COPD international survey. Eur Resp J 20 (2002) 799-805
10. Wouters E.F.M. Economic analysis of the confronting COPD survey: an overview of results. Resp Med 97 Supplement c (2003) S3-S14
11. Jansson S.-A., Andersson F., Borg S., Ericsson A., Jönsson E., and Lundbäck B. Costs of COPD in Sweden according to disease severity. Chest 122 (2002) 1994-2002
12. Andersson F., Borg S., Jansson S.-A., Jonsson A.-C., Ericsson A., Prütz C., et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Resp Med 96 (2002) 700-708
13. Spencer S., Calverley P.M.A., Burge P.S., Jones P.W., and on behalf of the ISOLDE Study Group. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 122-128
14. Mukamel D.B., Bajorska A., and Temkin-Greener H. Health care services utilization at the end of life in a managed care program integrating acute and long-term care. Med Care 40 (2002) 1136-1148
15. Hogan C., Lunney J., Gabel J., and Lynn J. Medicare beneficiaries' costs of care in the last year of life. Health Aff 20 (2001) 188-195
16. Stooker T., van Acht J.W., van Barneveld E.M., van Vliet R.C., van Hout B.A., Hessing D.J., et al. Costs in the last year of life in The Netherlands. Inquiry 38 (2001) 73-80
17. Hansen-Flaschen J. Chronic obstructive pulmonary disease: the last year of life. Resp Care 49 (2004) 90-98
18. Lynn J., Ely E.W., Zhong Z., Landrum K., Dawson N.V., Connors A., et al. Living and dying with chronic obstructive pulmonary disease. Geriatr Soc 48 (2000) s91-s100
19. Swedish National Board of Health and Welfare. Epidemiological centre. The national mortality registry (2003), Socialstyrelsen, Stockholm. http://www.sos.se/epc/dors/dodsreg.htm
20. Swedish National Board of Health and Welfare. Epidemiological centre. The national inpatient registry (2003), Socialstyrelsen, Stockholm. http://www.sos.se/epc/par/
21. Camilli A.E., Robbins D.R., and Lebowitz M.D. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 133 (1991) 795-800
22. Jousilahti P., Vartiainen E., Tuomilehto J., and Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 348 (1996) 567-572
23. Felder S., Meirer M., and Schmitt H. Health care expenditures in the last months of life. J Health Econ 19 (2000) 679-695
24. Huiart L., Ernst P., and Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 128 (2005) 2640-2646
25. Sidney S., Sorel M., Quesenberry Jr. C.P., Deluise C., Lanes S., and Eisner M.D. COPD and incident cardiovascular disease hospitalizations and mortality: kaiser permanente medical care program. Chest 128 (2005) 2068-2075
26. Langhammer A., Johnsen R., Gulsvik A., Holmen T.L., and Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Resp J 21 (2003) 1017-1023
27. Higgins M.W., and Keller J.B. Trends in COPD morbidity and mortality in Tecumseh, Michingan. Am Rev Resp Dis 140 (1989) S42-S48
28. Niederman M.S., McCombs J.S., Unger A.N., Kumar A., and Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Therap 21 (1999) 576-591